3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Pain
19
Neoplasms
18
Cancer Pain
6
Breast Neoplasms
5
Breakthrough Pain
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Colonic Neoplasms
4
Agnosia
4
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Head and Neck Neoplasms
3
Chronic Pain
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain, Postoperative
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Burns
2
Anemia, Sickle Cell
2
post laminectomy syndrome
1
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vipoma
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Interventions
Lidocaine
4
Oxycodone
2
Capsaicin
2
ziconotide
1
nabiximols
1
Vitamin B 6
1
Vitamin B 12
1
Vinorelbine
1
Vincristine
1
Transcutaneous Electric Nerve Stimulation
1
Transcranial Magnetic Stimulation
1
Thalidomide
1
Telmisartan
1
Tapentadol
1
Surveys and Questionnaires
1
Sodium Chloride
1
Pregabalin
1
Plastic Surgery Procedures
1
Paclitaxel
1
Oxaliplatin
1
Morphine
1
Methadone
1
Manipulation, Osteopathic
1
Lidoderm
1
Ketamine
1
KRN 5500
1
Hypnosis
1
Hydromorphone
1
Geritol
1
Gabapentin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neuralgia
×
Fentanyl
×
Clear all
NCT01946555
2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
150 enrolled